Form 4: Precision Biosciences Director Buys Shares
Insider Transaction (Form 4)
Stanley Frankel, a Director of Precision Biosciences Inc, purchased 1,000 shares of common stock on September 28, 2026 for $6.00 per share.
Summary
- Open-market purchase: acquired 1,000 Common Stock at $6.00 ($6,000) on September 28, 2026; holds 41,478 after (Direct).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $6,000, committing personal capital to the stock.
Insider Transactions
Stanley Frankel — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-28 | Open-market purchase | Common Stock | 1,000 | $6 | $6.0K | 41,478 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-28 | Open-market purchase (1,000 shares) |
Keywords
insider transaction, Form 4, DTIL, PRECISION BIOSCIENCES INC, bullish, Stanley Frankel
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.